Company identity
Company number 07880369
Company profile
UK company 07880369, incorporated on 13 December 2011.
Astrimmune Ltd is a UK company with status Active founded in 2011 based in East Midlands.
Company number 07880369
Financial period: 1 Apr 2023 to 31 Mar 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Oct 2017 to 30 Jun 2018
Can we detect and monitor bladder cancer with a urine test? For many patients with bladder cancer (BC), their cancer comes back after treatment and so they have to be regularly checked. These patients are checked with a cystoscope. This is a long thin flexible tube with a light and a camera at the end that is inserted into the urethra (the tube that carri...
1 Jun 2017 to 31 Mar 2018
We urgently need earlier detection of cancer and other diseases. Earlier detection leads to lower costs, better survival and higher quality of patient life by allowing earlier and more effective treatment options. Astrimmune responded to this challenge with an advanced filter product that allows the isolation of circulating tumour cells and other rare cel...
1 Dec 2015 to 29 Feb 2016
Astrimmune has developed Fluid-Flow Cell-Imaging as a non-invasive general cancer screen. We produce multiple label-free or labeled, moving and static images of cells in blood or urine. Images are created in different ways and consolidated using Astronomical Algorithms that have been applied to images of distant galaxies. When a suspicious cell is found w...
1 Jun 2015 to 30 Sep 2015
Digital technology has transformed the IT, communications, entertainment industries and social media and continues to make impressive inroads in medical diagnostics. We have conceived of a novel digital technique applied to the analysis of human blood in order to detect cancer at an earlier stage and to allow doctors to take better infomred, appropriate a...